¼¼°èÀÇ ³ú½Ç¿Ü¹è¾× ½ÃÀå
External Ventricular Drain
»óǰÄÚµå : 1786573
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 284 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,150,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,452,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

³ú½Ç¿Ü¹è¾× ¼¼°è ½ÃÀåÀº 2030³â±îÁö 90¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 71¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ³ú½Ç¿Ü¹è¾× ¼¼°è ½ÃÀåÀº 2024-2030³â ºÐ¼® ±â°£ µ¿¾È CAGR 4.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 90¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ¼Ò¾Æ ºÐ¾ß´Â CAGR 3.4%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 59¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼ºÀÎ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 5.3%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 19¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 7.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ³ú½Ç¿Ü¹è¾× ½ÃÀåÀº 2024³â¿¡ 19¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 18¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 7.2%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 1.7%¿Í 3.1%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 2.3%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ³ú½Ç¿Ü¹è¾× ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

³ú½Ç¿Ü¹è¾×À̶õ ¹«¾ùÀ̸ç, ½Å°æÇп¡¼­ ¿Ö Áß¿äÇѰ¡?

³ú½Ç¿Ü¹è¾×(EVD)´Â ¿Ü»ó¼º ³ú¼Õ»ó, ³ú¼öµÎÁõ, µÎ°³³»ÃâÇ÷, ³úÁ¾¾ç µîÀÇ Áõ»óÀ¸·Î ÀÎÇÑ µÎ°³³»¾ÐÀ» ¿ÏÈ­Çϱâ À§ÇØ ½Å°æ¿Ü°ú ¹× ÁßȯÀÚ½Ç(ICU)¿¡¼­ »ç¿ëµÇ´Â Áß¿äÇÑ ÀÇ·áÀåºñÀÔ´Ï´Ù. ÀÌ ¹è¾×°üÀº °úµµÇÑ ³úô¼ö¾×(CSF)À» ÀϽÃÀûÀ¸·Î ³ú½Ç·ÎºÎÅÍ ¿ÜºÎ·Î ¹èÃâÇÏ¿© ³ú½ÇÅ»ÃâÁõ°ú °°Àº »ý¸íÀ» À§ÇùÇÏ´Â ÇÕº´ÁõÀ» ¿¹¹æÇÕ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ½Å°æ Áúȯ ¹× µÎºÎ ¿Ü»ó »ç·Ê°¡ Áõ°¡ÇÔ¿¡ µû¶ó EVD¿¡ ´ëÇÑ ¼ö¿ä´Â Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

EVD´Â µÎ°³³»¾Ð »ó½ÂÀ» °ü¸®ÇÒ ¼ö ÀÖ´Â Áï°¢ÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇϰí, ÀÇ·áÁøÀÌ È¯ÀÚ¸¦ ¾ÈÁ¤½ÃŰ°í ½Å°æÇÐÀû »óŸ¦ È¿°úÀûÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁֱ⠶§¹®¿¡ ÁßȯÀÚ Ä¡·á ȯ°æ¿¡¼­ EVDÀÇ Á߿伺Àº ¾Æ¹«¸® °­Á¶Çصµ Áö³ªÄ¡Áö ¾Ê½À´Ï´Ù. ÀÌ ÀåÄ¡´Â Á¤È®ÇÑ ¼ö¾× ¹èÃâ°ú ¾Ð·Â Á¶ÀýÀÌ ÇÊ¿äÇÑ ½Å°æ¿Ü°ú ¼ö¼ú ¹× ¼ö¼ú ÈÄ °ü¸®¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ³úÁ¹Áß, µ¿¸Æ·ù, ½Å°æ À§±â »óÅÂÀÇ Áõ°¡·Î ÀÎÇØ EVD´Â Çö´ë ½Å°æ¿Ü°ú Áø·á¿¡ ÇʼöÀûÀÎ ¿ä¼Ò°¡ µÇ¾úÀ¸¸ç, ¿¬±¸¿Í ±â¼ú Çõ½Å¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±â¼úÀÌ ³ú½Ç¿Ü¹è¾× ½Ã½ºÅÛÀ» ¾î¶»°Ô °³¼±Çϰí Àִ°¡?

ÀÇ·á±â¼úÀÇ ¹ßÀüÀº EVD ½Ã½ºÅÛÀÇ Á¤È®¼º, ¾ÈÀü¼º, »ç¿ë ÆíÀǼºÀ» Çâ»ó½ÃÄÑ EVD ½Ã½ºÅÛÀ» Å©°Ô °³¼±Çϰí ÀÖ½À´Ï´Ù. ±âÁ¸ÀÇ EVD´Â ÀÇ·á Àü¹®°¡ÀÇ ¼öµ¿ Á¶Á¤ÀÌ ÇÊ¿äÇßÁö¸¸, ÃֽŠÀåºñ¿¡´Â µðÁöÅÐ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÌ ³»ÀåµÇ¾î ÀÖ¾î ¼ö¾× ¹èÃâÀ» ÀÚµ¿À¸·Î Á¤È®ÇÏ°Ô Á¶Á¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½º¸¶Æ® EVD´Â ¾Ð·Â ¼¾¼­¿Í ÀüÀÚ ¹ëºê ½Ã½ºÅÛÀ» °®Ãß°í ÀÖ¾î ³ú½Ç½ÅÀ̳ª Áö¼ÓÀûÀÎ µÎ°³³»¾Ð »ó½Â°ú °°Àº ½É°¢ÇÑ ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ´Â °ú¹è¾× ¹× °ú¼Ò¹è¾× À§ÇèÀ» ÁÙ¿©ÁÝ´Ï´Ù.

ÀÚµ¿È­ ¿Ü¿¡µµ °¨¿° ´ëÃ¥µµ EVD ±â¼ú Çõ½ÅÀÇ Áß¿äÇÑ ºÐ¾ßÀÓ¿¡´Â º¯ÇÔÀÌ ¾ø½À´Ï´Ù. EVD´Â ³ú¿¡ Á÷Á¢ Á¢±ÙÇϱ⠶§¹®¿¡ ³ú½Ç¿° µîÀÇ °¨¿° À§ÇèÀÌ ³ô½À´Ï´Ù. ÀÌ·¯ÇÑ À§ÇèÀ» ÁÙÀ̱â À§ÇØ Á¦Á¶¾÷üµéÀº Ç×±Õ ÄÚÆÃÀÌ µÈ Ä«Å×ÅÍ¿Í ¼¼±Õ ¿À¿°À» ÃÖ¼ÒÈ­ÇÏ´Â Æó¼âÇü ¹è¼ö ½Ã½ºÅÛÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù. »ýüÀûÇÕ¼º Àç·á¿Í Ç×±Õ Àç·áÀÇ ÅëÇÕÀº ȯÀÚÀÇ ¾ÈÀüÀ» Çâ»ó½Ãų »Ó¸¸ ¾Æ´Ï¶ó Ä«Å×ÅÍ °ü·Ã °¨¿°ÀÇ ºóµµ¸¦ °¨¼Ò½ÃÄÑ È¯ÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí ÀÔ¿ø ±â°£À» ´ÜÃà½Ãų ¼ö ÀÖ½À´Ï´Ù.

³ú½Ç¿Ü¹è¾× ½ÃÀåÀÇ ¼ºÀå ÃËÁø¿äÀÎÀº?

³ú½Ç¿Ü¹è¾× ½ÃÀåÀº ½Å°æ Àå¾Ö »ç·ÊÀÇ Áõ°¡, ½Å°æ¿Ü°ú ±â¼úÀÇ ¹ßÀü, ½Å°æ°è ÁßȯÀÚ Ä¡·á¿¡¼­ Á¶±â °³ÀÔÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. »ç°í, ½ºÆ÷Ã÷ ¿Ü»ó, ³«»ó µîÀ¸·Î ÀÎÇÑ ¿Ü»ó¼º ³ú¼Õ»ó À¯º´·üÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ƯÈ÷ °í·ÉÈ­ »çȸ¿¡¼­ EVD ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ƯÈ÷ ½ÅÈï½ÃÀå¿¡¼­ÀÇ ½Å°æ¿Ü°ú ÀÎÇÁ¶ó ±¸ÃàÀÌ ÀÌ·¯ÇÑ ±¸¸íÀåÄ¡ÀÇ º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

³ú½Ç¿Ü¹è¾× ½ÃÀåÀÇ ¼ºÀåÀº ½º¸¶Æ® ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ ±â¼ú ¹ßÀü, ½Å°æ°è Áúȯ Ä¡·á¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ³úÁ¹Áß ¹× ¿Ü»ó¼º ³ú¼Õ»ó ¹ß»ý·ü Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÀÇ·á ¹× ÀÇ·á ¼­ºñ½º Á¦°øÀڴ ȯÀÚÀÇ ¾ÈÀü°ú °¨¿° ¿¹¹æÀ» ¿ì¼±½ÃÇϰí ÀÖÀ¸¸ç, Ç×±Õ Æ¯¼ºÀ» °¡Áø EVD ¹× ÀÚµ¿ ¾Ð·Â Á¶Àý ½Ã½ºÅÛ Ã¤ÅÃÀ» Àå·ÁÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½Å°æ¿Ü°ú ¼ö¼úÀÇ Ä¡·á ¼ºÀû Çâ»óÀ» À§ÇÑ Á¤ºÎÀÇ ³ë·Â°ú ¿¬±¸°³¹ß ÀÚ±ÝÀÌ Â÷¼¼´ë EVDÀÇ °³¹ßÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. º¸´Ù Á¤È®ÇÏ°í ¾ÈÀüÇÑ ½Å°æÇÐÀû °³ÀÔ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡ÇÔ¿¡ µû¶ó ³ú½Ç¿Ü¹è¾×°ü ½ÃÀåÀº Çõ½Å, ÀÇ·á ¼­ºñ½º Á¢±Ù¼º Çâ»ó, ÀÇ·á±â±â ±â¼ú ¹ßÀü¿¡ ÈûÀÔ¾î Áö¼ÓÀûÀ¸·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎ¹®

ȯÀÚ(¼Ò¾Æ, ¼ºÀÎ), ¿ëµµ(¿Ü»ó¼º ³ú¼Õ»ó ¿ëµµ, ÁöÁÖ¸·ÇÏÃâÇ÷ ¿ëµµ, ³ú³»ÃâÇ÷ ¿ëµµ, ºñ¿Ü»ó¼º ¼öµÎÁõ »óÅ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»ç ¼ÒÀçÁö, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±âÁØÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº Ç϶ô, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global External Ventricular Drain Market to Reach US$9.0 Billion by 2030

The global market for External Ventricular Drain estimated at US$7.1 Billion in the year 2024, is expected to reach US$9.0 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. Pediatric, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$5.9 Billion by the end of the analysis period. Growth in the Adult segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.9 Billion While China is Forecast to Grow at 7.2% CAGR

The External Ventricular Drain market in the U.S. is estimated at US$1.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 7.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Global External Ventricular Drain Market - Key Trends & Drivers Summarized

What Are External Ventricular Drains and Why Are They Crucial in Neurology?

External ventricular drains (EVDs) are critical medical devices used in neurosurgery and intensive care units (ICUs) to relieve intracranial pressure caused by conditions such as traumatic brain injury, hydrocephalus, intracranial hemorrhage, and brain tumors. These drains temporarily divert excess cerebrospinal fluid (CSF) from the brain’s ventricles to an external drainage system, preventing life-threatening complications such as brain herniation. As neurological disorders and head trauma cases increase globally, the demand for EVDs continues to rise.

The importance of EVDs in critical care settings cannot be overstated, as they provide an immediate solution for managing elevated intracranial pressure, allowing healthcare providers to stabilize patients and monitor their neurological status effectively. These devices play a vital role in neurosurgical procedures and postoperative care, where precise CSF drainage and pressure regulation are necessary. The growing incidence of stroke, aneurysms, and neurocritical conditions has made EVDs indispensable in modern neurosurgical practices, leading to increased investments in research and innovation.

How Is Technology Improving External Ventricular Drain Systems?

Advancements in medical technology have led to significant improvements in EVD systems, enhancing their accuracy, safety, and ease of use. Traditional EVDs require manual adjustments by healthcare professionals, but modern devices now incorporate digital monitoring systems that allow for automated and precise regulation of CSF drainage. These smart EVDs are equipped with pressure sensors and electronic valve systems, reducing the risk of over-drainage or under-drainage, which can lead to serious complications such as brain collapse or continued intracranial hypertension.

In addition to automation, infection control remains a key area of innovation in EVD technology. Since EVDs involve direct access to the brain, they pose a high risk of infections such as ventriculitis. To mitigate this risk, manufacturers are developing antimicrobial-coated catheters and closed-system drainage setups that minimize bacterial contamination. The integration of biocompatible and antimicrobial materials not only enhances patient safety but also reduces the frequency of catheter-related infections, leading to better patient outcomes and shorter hospital stays.

What Are the Key Drivers of Growth in the External Ventricular Drain Market?

The external ventricular drain market is expanding due to increasing cases of neurological disorders, advancements in neurosurgical techniques, and heightened awareness of the importance of early intervention in neurocritical care. The rising prevalence of traumatic brain injuries caused by accidents, sports injuries, and falls-particularly among aging populations-has significantly increased the demand for EVD systems. Additionally, improvements in neurosurgical infrastructure, particularly in emerging markets, are facilitating the wider adoption of these life-saving devices.

The growth in the external ventricular drain market is driven by several factors, including technological advancements in smart monitoring systems, increasing investments in neurocritical care, and the rising incidence of stroke and traumatic brain injuries. Hospitals and healthcare providers are prioritizing patient safety and infection prevention, prompting the adoption of EVDs with antimicrobial properties and automated pressure regulation systems. Additionally, government initiatives and research funding aimed at improving neurosurgical outcomes are accelerating the development of next-generation EVDs. As the demand for precise and safer neurological interventions continues to grow, the external ventricular drain market is expected to witness sustained expansion, driven by innovation, improved healthcare accessibility, and advancements in medical device technology.

SCOPE OF STUDY:

The report analyzes the External Ventricular Drain market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Patient (Pediatric, Adult); Application (Traumatic Brain Injury Application, Subarachnoid Hemorrhage Application, Intracerebral Hemorrhage Application, Non-Traumatic Hydrocephalus Condition Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 47 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â